CN
  • Shanghai Bao Pharmaceuticals Co., Ltd. focuses on the development and commercialization of recombinant protein drugs and antibody drugs. We are currently building a modern GMP-compliant biopharmaceutical industrialization base with a total investment of more than RMB 900 million in Luodian Industrial Park, Baoshan District, Shanghai. According to the design, the base will have multiple drug substance production lines for mammalian cell expression system and Escherichia coli/yeast expression system, covering drug product lines of aqueous solution for injection, lyophilized powder for injection and pre-filled disposable injection. It is expected that the first phase of the project will be put into operation within 2 years .
  • Products
    Therapeutic Area
    Phase
  • ProductsKJ017
    FieldMulti-domain
    Phase III
    Phase III
  • ProductsKJ101
    FieldMulti-domain
    Pre-clinical
    Pre-clinical
  • ProductsKJ103
    FieldMulti-domain
    Phase II
    Phase II
  • ProductsKJ036
    FieldTumor
    Pre-clinical
    Pre-clinical
  • ProductsKJ015
    FieldTumor
    Pre-clinical
    Pre-clinical
  • ProductsSJ01
    FieldAnemia
    Phase I
    Phase I
  • ProductsSJ02
    FieldAssisted Reproduction
    Phase III
    Phase III
  • ProductsSJ03
    FieldAssisted Reproduction
    Pre-clinical
    Pre-clinical
  • ProductsSJ04
    FieldAssisted Reproduction
    Pre-clinical
    Pre-clinical
  • ProductsSJ05
    FieldAssisted Reproduction
    Pre-clinical
    Pre-clinical
  • ProductsSJ06
    FieldAssisted Reproduction
    Pre-clinical
    Pre-clinical
  • ProductsSJ11
    FieldAssisted Reproduction
    Pre-clinical
    Pre-clinical